SVS PSO VQI Regional Meeting: Midwest Vascular Collaborative

April 12, 2024
Registration


This is a private course, and registrations are not being accepted.
 

Purpose

The Society for Vascular Surgery Patient Safety Organization (SVS PSO) improves the quality, safety, effectiveness, and cost of vascular healthcare by collecting and exchanging information through regional quality improvement groups.

Professional Practice Gap

Each regional group is provided with benchmark reports to compare their center/region/national outcomes to focus on quality improvement to meet the mission of the SVS PSO.  Some examples include metrics on:

  • Length of stay (cost) 
  • Long-term follow-up of patients (quality)
  • Clinical outcomes, such as mortality and stroke (quality/safety)
  • Use of Statins and Antiplatelets to decrease mortality (effectiveness) 
  • Adherence to scientific guidelines to optimize patient care (quality/safety/effectiveness) 

By reviewing their benchmarks during these bi-annual meetings, each site and region can focus quality improvement efforts to improve and track their success over time. 

Learning Objectives

  • Establish quality improvement goals for vascular patients and their centers using the Vascular Quality Initiative (VQI) regional reports.
  • Interpret and compare each center's VQI results to regional and national benchmarked data.
  • Learn, through group discussion, the VQI regional report results to improve the quality of vascular health care by monitoring measurable performance indicators, SVS PSO evidence-based research, and outcomes.
  • Identify high-performing regional vascular centers to discuss variations in care and clinical practice patterns to improve outcomes and prompt quality improvement recommendations for vascular care patients.
  • Share of best practices/pathways of care.

Agenda

The agenda is in the local time. 

TimeTopicCE Credit
4:00 pm

Regional Data Review and Quality Improvement Proposal

Eleftherios S. Xenos, MD, PhD, RVT, FACS
Regional Medical Director, Midwest Vascular Collaborative

Yes
5:00 pm

National VQI Update

Betsy Wymer, RN
Director of Quality - PSO

Yes
5:45 pm

Council and Committee Updates

No
6:00 pmAdjournNo
Course summary
Available credit: 
  • 1.75 AMA PRA Category 1 Credits™
  • 1.75 AOA Category 2­A
  • 1.75 CE Contact Hour(s)
  • 1.75 IBON
Course opens: 
04/12/2024
Course expires: 
04/12/2024
Event starts: 
04/12/2024 - 4:00pm CDT
Event ends: 
04/12/2024 - 6:00pm CDT
Cost:
$0.00
Add to calendar: 
Rating: 
0

Accreditation Statements

  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Society for Vascular Surgery Patient Safety Organization. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.75 continuing education contact hour(s). No partial credit is awarded.
  • Other healthcare professionals: This live activity is designated for 1.75 AMA PRA Category 1 Credit(s)TM. 

Educational Grants

Thanks to the following companies for the generous financial support of this continuing education activity.

  • Cook Medical, LLC
  • W.L. Gore & Associates, Inc.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Click here to view the disclosures.

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. The content of this educational offering does not reflect the views of Des Moines University Medicine and Health Sciences.

Available Credit

  • 1.75 AMA PRA Category 1 Credits™
  • 1.75 AOA Category 2­A
  • 1.75 CE Contact Hour(s)
  • 1.75 IBON

Price

Cost:
$0.00
Please login or Create an Account to take this course.

This is a private course, and registrations are not being accepted.